Autonomix Medical, Inc.AMIX
ASignal's systematic analysis rates AMIX as Bearish.
Reflects the latest available analysis · analyzed Aug 21, 2026
The case on AMIX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong current ratio (4.85x) indicating solid short-term liquidity
- Zero debt with $3.46M in cash suggesting balance sheet resilience
- Price trading below book value (P/B of 0.90x) may indicate undervaluation
- Negative return on equity (-315.99%) and return on assets (-157.81%) signaling severe profitability issues
- Negative operating cash flow (-$13.22M) and free cash flow (-$7.24M) indicating cash burn
- MACD below signal line with negative histogram, suggesting bearish momentum
- Price below 20-day and 50-day moving averages with negative price momentum
- No Reddit mentions and low news coverage (2 sources), indicating minimal market interest
See the full verdict on AMIX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AMIX
Most investors never get a second opinion, let alone several. ASignal runs AMIX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.